Han, Guohong
4 papers on CoChatORCID 0000-0003-4568-3776
Most cited papers
- Verified
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Kudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet
Hepatocellular Carcinoma Treatment and PrognosisColorectal Cancer Treatments and Studies
Cited by 5,497
- Verified
The role of hepatic resection in the treatment of hepatocellular cancer
Roayaie, S., Jibara, G., Tabrizian, P., Park, J., Yang, J., Yan, L., Schwartz, M., Han, G., Izzo, F., Chen, M., et al. (2015) · Hepatology
Hepatocellular Carcinoma Treatment and PrognosisRenal cell carcinoma treatment
Cited by 420
- Verified
Find Duplicates among the PubMed, EMBASE, and Cochrane Library Databases in Systematic Review
Qi, X., Yang, M., Ren, W., Jia, J., Wang, J., Han, G., & Fan, D. (2013) · PLoS ONE
Meta-analysis and systematic reviewsscientometrics and bibliometrics research
Cited by 98
- Verified
Garsorasib, a KRAS G12C inhibitor, with or without cetuximab, an EGFR antibody, in colorectal cancer cohorts of a phase II trial in advanced solid tumors with KRAS G12C mutation
Ruan, D.-Y., Wu, H.-X., Xu, Y., Munster, P. N., Deng, Y., Richardson, G., Yan, D., Lee, M.-A., Lee, K.-W., Pan, H., et al. (2025) · Signal Transduction and Targeted Therapy
Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free